Grünenthal GmbH: Neuralgia trials

The registry lists 10 Neuralgia studies with Grünenthal GmbH as lead sponsor. 0 are open to participants now and 4 have results posted.

Phase 1 1Phase 2 2Phase 3 5Phase 4 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.CompletedNCT01838616Phase 4Results posted
• A Study to Assess the Safety and Efficacy of 7 Days Treatment With a Novel Analgesic in Subjects With Peripheral Neuropathic PainTerminatedNCT01485094Phase 2Results posted
• Comparison of Increasing Doses of Tapentadol Versus a Combination of Tapentadol and PregabalinCompletedNCT01352741Phase 4Results posted
• Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking WHO Step III Analgesics But Showing a Lack of TolerabilityTerminatedNCT00986258Phase 3Results posted
• A Clinical Study in Healthy Women Which Aims to Explore the Intestinal Uptake of Two Different Tablets of GRTA9906 Into the Body and the Effect of Food on itCompletedNCT03765801Phase 1
• A Study With Lidocaine 5% Medicated Plaster in Patients Suffering From Postherpetic NeuralgiaCompletedNCT03765697Phase 3
• A Study With Lido-Patch and Placebo Plaster in Patients Suffering From Postherpetic Neuralgia (PHN)CompletedNCT03745404Phase 3
• Efficacy and Tolerability of Lidocaine Plaster for Treatment of Long-term Local Nerve PainCompletedNCT01752322Phase 3
• Lidocaine 5% Medicated Plaster in Chronic Neuropathic Postoperative PainTerminatedNCT01155986Phase 2
• Efficacy and Safety of Topical Versus Systemic Treatment in Postherpetic Neuralgia and Diabetic Polyneuropathic PainCompletedNCT00414349Phase 3